IL10RA and inflammatory bowel disease: At 0.5 ng/mL IL-10 stimulation, 24 variants that were identified in patients with infantile-onset IBD, including the 8 previously validated LOF variants in IL10RA, showed a statistically significant decrease STAT3 phosphorylation, demonstrating LOF.